#survival — Thursday, January 22, 2026 (1 items)
| 0 | 💬 0 |
Nivolumab for Resected Stage III or IV Melanoma at 9 Years.
(nejm.org)
|
New England Journal of Medicine 2026-01-22 | #immunotherapy #melanoma #survival #checkpoint inhibitor |